bioRxivBioinformaticsPreprint
Adaptation of Graph Convolutional Neural Networks and Graph Layer-wise Relevance Propagation to the Spektral library with application to gene expression data of Colorectal Cancer patients
Sebastian Lutz, Florian AueriD, Dennis HartmanniD, Hryhorii CheredaiD, Tim BeißbarthiD, Frank KrämeriD
Abstract
MotivationColorectal Cancer has the second-highest mortality rate worldwide, which requires advanced diagnostics and individualized therapies to be developed. Information about the interactions between molecular entities provides valuable information to detect the responsible genes driving cancer progression. Graph Convolutional Neural Networks are able to utilize the prior knowledge provided by interaction networks and the Spektral library adds a performance increase in contrast to standard implementations. Furthermore, machine learning technology shows great potential to assist medical professionals through guided clinical decision support. However, the deep learning models are limited in their application in precision medicine due to their lack to explain the factors contributing to a prediction. Adaption of the Graph Layer-Wise Relevance Propagation methodology to graph-based deep learning models allows to attribute the learned outcome to single genes and determine their relevance. The resulting patient-specific subnetworks then can be used to identify potentially targetable genes. ResultsWe present an implementation of Graph Convolutional Neural Networks using the Spektral library in combination with adapted functions for Graph Layer-Wise Relevance Propagation. Deep learning models were trained on a newly composed large gene expression dataset of Colorectal Cancer patients with different molecular interaction networks as prior knowledge: Protein-protein interactions from the Human Protein Reference Database and STRING, and pathways from the Reactome database. Our implementation performs comparably with the original implementation while reducing the computation time, especially for large networks. Further, the generated subnetworks are similar to those of the initial implementation and reveal possible, and even more distant, biomarkers and drug targets. AvailabilityThe implementation details and corresponding dataset including their visualizations can be found at https://github.com/frankkramer-lab/spektral-gcnn-glrp-on-crc-data Contactsebastian.lutz@uni-a.de
- organism: human
- assay: bulk RNA-seq
- research focus: gene regulatory network inference
- research focus: differential expression
- approach: deep learning
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Explaining decisions of Graph Convolutional Neural Networks: patient-specific molecular subnetworks responsible for metastasis prediction in breast cancer
Hryhorii Chereda, Annalen Bleckmann, … Tim Beißbarth·Genome MedicinePeer-reviewed·Mar 11, 2021
- Network-guided supervised learning on gene expression using a graph convolutional neural network
Hatairat Yingtaweesittikul, Chayaporn Suphavilai·bioRxiv·Dec 27, 2021
- Benchmarking Graph Neural Networks for Multi-Omics Cancer Subtyping using Methylation and Gene Expression Profiles
Julia Schirmacher, M. Mäurer, … Anne-Christin Hauschild·bioRxiv·Aug 25, 2026
- Gra-CRC-miRTar: The pre-trained nucleotide-to-graph neural networks to identify potential miRNA targets in colorectal cancer
Rui Yin, Hongru Zhao, … Mingyi Xie·Computational and Structural Biotechnology JournalPeer-reviewed·Jul 17, 2024
- GNN-SubNet: disease subnetwork detection with explainable Graph Neural Networks
Bastian Pfeifer, Afan Secic, … Andreas Holzinger·BioinformaticsPeer-reviewed·Aug 24, 2022
- Stability of feature selection utilizing Graph Convolutional Neural Network and Layer-wise Relevance Propagation
Hryhorii Chereda, Andreas Leha, Tim Beißbarth·Artificial Intelligence in MedicinePeer-reviewed·Mar 11, 2024